- Clinical Trials
- April 2024
- 40 Pages
Global
From €1199EUR$1,250USD£1,030GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,038GBP
- Report
- January 2022
- 200 Pages
Global
From €7195EUR$7,500USD£6,181GBP
- Report
- January 2022
- 60 Pages
Global
From €3789EUR$3,950USD£3,255GBP
- Report
- June 2021
- 48 Pages
Global
- Report
- April 2022
- 120 Pages
Global
From €2398EUR$2,500USD£2,060GBP
- Drug Pipelines
- July 2020
- 85 Pages
Global
From €1919EUR$2,000USD£1,648GBP
- Drug Pipelines
- March 2021
Global
From €1919EUR$2,000USD£1,648GBP
Smallpox is a highly contagious and potentially fatal infectious disease caused by the variola virus. Smallpox was declared eradicated in 1980, however, the threat of a bioterrorist attack using the virus has led to the development of drugs to treat the disease.
The smallpox drug market is a subset of the infectious diseases drugs market. It includes drugs used to treat smallpox, as well as vaccines to prevent it. Vaccines are the primary form of prevention, but antiviral drugs are also used to treat the disease. These drugs work by targeting the virus and preventing it from replicating.
The smallpox drug market is highly competitive, with several companies developing drugs and vaccines. These include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more